Skip to main content
FP·EDITORIAL · VOL. III · ISSUE 14 · UNITED STATES · MAY 2026 last sweep 2026-05-14 · 2 programs scored · 1 defunct

CBUAE · United Arab Emirates · United States

methodology v3.2 · audited apr '26

iso 27001 · CompaniesHouse #OC4451x

Vol. III · §5 · United Arab Emirates

CBUAE

Central Bank of the United Arab Emirates

Jurisdiction
United Arab Emirates
Applies to (niches)
business-banking · crypto-exchange · money-transfer · neobank · credit-card · personal-loan
Source
www.centralbank.ae (opens in new tab)

The Central Bank of the United Arab Emirates is the federal banking and payments regulator covering all seven emirates. Its perimeter sits over the UAE-mainland market — distinct from the free-zone regulators ADGM (Abu Dhabi) and DFSA (Dubai) — and is the dominant regulator for FintechPays’ UAE business-banking, money-transfer, and credit-card cells.

For affiliate programs targeting UAE mainland users, CBUAE supervision matters in three concrete ways FintechPays surfaces. First, the Retail Payment Services and Card Schemes Regulation governs every payment-services provider serving UAE retail customers, which sweeps in remittance, wallets, BNPL, and most non-bank money-movement programs we cover. Second, the Stored Value Facilities (SVF) framework licences e-money issuers — the UAE analogue of UK EMI permissions — and is the gating regulator for most neobank-style programs. Third, the Retail Crypto-asset framework (issued jointly with the Securities and Commodities Authority) overlays crypto-exchange programs operating onshore, in addition to whatever free-zone licence the firm holds.

We score CBUAE supervision distinctly from free-zone authorisation in every UAE program review because they answer different questions. A firm with only ADGM/DFSA authorisation can serve free-zone clients but not the UAE-federal retail market without additional CBUAE permission. Where a program claims “UAE-regulated” without specifying which regulator, FintechPays asks for the licence number and verifies it against the relevant register before publishing the regulator pill.

Annex · cited by

Programs in our corpus that cite CBUAE

Editorial signatures and issue metadata

Edited by

Maren Holst

Senior Editor

Signed · M.HOLST

Fact-checked by

Asha Devi

Standards Desk (Fact-Checker)

Signed · A.DEVI

Issue meta

vol iii · iss 14

published 2026-03-12

last sweep 2026-05-14

methodology v3.2 · audited apr '26

Companies House #OC4451x